Table I.
Comparison of clinical characteristics between the PCOS and control groups.
| Variables | PCOS group (n=38) | Control group (n=35) | P-value |
|---|---|---|---|
| Age (year) | 29.60±0.66 | 29.66±0.82 | 0.960 |
| Infertility duration (year) | 4.62±0.50 | 4.64±0.55 | 0.974 |
| Menarche age (year) | 13.29±0.17 | 13.46±0.18 | 0.493 |
| Body mass index (Kg/m2) | 25.25±0.59 | 22.63±0.53 | 0.002 |
| Basal hormone levels | |||
| LH (mIU/ml) | 8.10±0.69 | 5.50±0.59 | 0.005 |
| FSH (mIU/ml) | 6.94±0.32 | 8.71±0.61 | 0.013 |
| E2 (pg/ml) | 90.43±11.85 | 88.80±12.95 | 0.926 |
| P (ng/ml) | 0.62±0.09 | 0.50±0.06 | 0.275 |
| T (ng/ml) | 45.09±3.66 | 41.58±3.60 | 0.498 |
| LH/FSH | 1.21±0.10 | 0.66±0.07 | <0.001 |
| IVF outcomes | |||
| No. of oocytes retrieved | 25.53±2.22 | 17.09±1.58 | 0.003 |
| MII oocyte rate | 0.75±0.03 | 0.82±0.03 | 0.093 |
| Fertilization rate | 0.72±0.03 | 0.81±0.02 | 0.012 |
| Cleavage rate | 0.85±0.03 | 0.92±0.02 | 0.049 |
| Embryo rate | 0.57±0.03 | 0.57±0.04 | 0.909 |
Data are presented as the mean ± SEM. P<0.05 was considered to indicate a statistically significant difference. PCOS, polycystic ovary syndrome; LH, luteinizing hormone; FSH, follicle stimulating hormone; E2, estrogen; P, progesterone; T, testosterone; MII, metaphase II; IVF, in vitro fertilization.